Novartis to Launch Its Own Branded Version of a Leading Multiple ...
PharmaLive.com (press release) - Newtown,PA,USA
"As a truly new treatment approach with once-daily oral dosing, we believe FTY720 can offer significant therapeutic benefits to MS patients." ...
See all stories on this topic

---

Teenager gets radical MS drug on NHS
Scotsman - Edinburgh,Scotland,UK
The 16-year-old, from Gullane, has successfully applied to NHS Lothian to use Tysabri, at a cost of £15000 a year, despite a ruling by drugs officials that ...
See all stories on this topic